T.-Y. Kim
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Viral-associated cancers and disorders
Papers in ⓘ
- Oncology 13
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 4
- HER2/EGFR in Cancer Research 2
-
- Gastric Cancer Management and Outcomes 5
- Renal cell carcinoma treatment 2
- Co-authors
- Masatoshi Kudo (3 shared papers)Ann‐Lii Cheng (3 shared papers)Philippe Merle (1 shared paper)Ahmed O. Kaseb (1 shared paper)Chen Huang (1 shared paper)Peter R. Galle (3 shared papers)Zhen Xu (1 shared paper)Wendy Verret (3 shared papers)
- Journals
- Annals of Oncology (13 papers)ESMO Open (2 papers)Clinical & Translational Oncology (1 paper)International Journal of Solids and Structures (1 paper)Clinical Radiology (1 paper)
- Partner nations
- South KoreaUnited StatesTaiwan
In The Last Decade
T.-Y. Kim
19 papers receiving 399 citations
Peers
Comparison fields: 5 of 58
- Hepatology 126
- Oncology 210
- Gastroenterology 30
- Pathology and Forensic Medicine 74
- Pulmonary and Respiratory Medicine 125
Countries citing papers authored by T.-Y. Kim
This map shows the geographic impact of T.-Y. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.-Y. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.-Y. Kim more than expected).
Fields of papers citing papers by T.-Y. Kim
This network shows the impact of papers produced by T.-Y. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.-Y. Kim. The network helps show where T.-Y. Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside T.-Y. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 150 | |
| 2 | 2016 | 55 | |
| 3 | 2008 | 37 | |
| 4 | 2017 | 35 | |
| 5 | 2016 | 32 | |
| 6 | 2023 | 27 | |
| 7 | 2008 | 26 | |
| 8 | 2024 | 8 | |
| 9 | 2016 | 7 | |
| 10 | 2018 | 5 | |
| 11 | 2016 | 4 | |
| 12 | 2016 | 4 | |
| 13 | 2015 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2019 | 1 |
About T.-Y. Kim
T.-Y. Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Pathology and Forensic Medicine, having authored 19 papers that have together received 406 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), HER2/EGFR in Cancer Research (2 papers), Liver physiology and pathology (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Hepatology (126 citations), Oncology (210 citations), Gastroenterology (30 citations), Pathology and Forensic Medicine (74 citations) and Pulmonary and Respiratory Medicine (125 citations). T.-Y. Kim has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Masatoshi Kudo, Ann‐Lii Cheng, Philippe Merle, Ahmed O. Kaseb, Chen Huang, Peter R. Galle, Zhen Xu, Wendy Verret, Masafumi Ikeda and Ho Yeong Lim. Their work appears in journals such as Annals of Oncology, ESMO Open, Clinical & Translational Oncology, International Journal of Solids and Structures and Clinical Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.